Cargando…
Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins
Hepatocellular carcinoma (HCC) is one of the most common and deadly malignant tumors in the world, especially in China. Follistatin‐like protein 5 (FSTL5) is a member of the FSTL family, which is involved in cell proliferation, migration, differentiation, and embryo development. We aimed to investig...
Autores principales: | Li, Chunlei, Dai, Lei, Zhang, Junfeng, Zhang, Yujing, Lin, Yi, Cheng, Lin, Tian, Hongwei, Zhang, Xin, Wang, Qingnan, Yang, Qianmei, Wang, Yuan, Shi, Gang, Cheng, Fuyi, Su, Xiaolan, Yang, Yang, Zhang, Shuang, Yu, Dechao, Wei, Yuquan, Deng, Hongxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237577/ https://www.ncbi.nlm.nih.gov/pubmed/30255547 http://dx.doi.org/10.1111/jcmm.13906 |
Ejemplares similares
-
DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle
por: Cheng, Lin, et al.
Publicado: (2017) -
IL‐35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells
por: Wang, Yuan, et al.
Publicado: (2017) -
A Novel Antitumor Strategy: Simultaneously Inhibiting Angiogenesis and Complement by Targeting VEGFA/PIGF and C3b/C4b
por: Wang, Huiling, et al.
Publicado: (2019) -
A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity
por: Tian, Hongwei, et al.
Publicado: (2016) -
Author Correction: A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity
por: Tian, Hongwei, et al.
Publicado: (2019)